JORGE ANDRADE: Open Payments
NPI 1942261490 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,615 in 200 payments from 35 companies in 2025. Trend: 2023 $2,905 · 2024 $4,429 · 2025 $3,615
Food & beverage: $3,610Education: $6
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $393 |
| Novo Nordisk Inc | 18 | $355 |
| AstraZeneca Pharmaceuticals LP | 11 | $343 |
| Ardelyx, Inc. | 15 | $222 |
| PFIZER INC. | 13 | $206 |
| Novartis Pharmaceuticals Corporation | 11 | $194 |
| Otsuka America Pharmaceutical, Inc. | 13 | $184 |
| Lilly USA, LLC | 12 | $167 |
| Esperion Therapeutics, Inc. | 13 | $164 |
| Verona Pharma, Inc. | 8 | $144 |
Products named: VRAYLAR, IBSRELA, FARXIGA, REXULTI, LEQVIO, NEXLETOL, Ozempic, Ohtuvayre.
Industry payments across MA — which companies pay providers there.
